Rajiv Patni - Net Worth and Insider Trading
Rajiv Patni Net Worth
The estimated net worth of Rajiv Patni is at least $166,379 dollars as of 2024-12-27. Rajiv Patni is the Chief Medical Officer of Adamas Pharmaceuticals Inc and owns about 19,141 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $157,339. Rajiv Patni is also the Chief Development Officer of Ocera Therapeutics Inc and owns about 5,050 shares of Ocera Therapeutics Inc (OCRX) stock worth over $9,040. Details can be seen in Rajiv Patni's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rajiv Patni has not made any transactions after 2019-03-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rajiv Patni
Rajiv Patni Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rajiv Patni owns 4 companies in total, including Portola Pharmaceuticals Inc (PTLA) , Adamas Pharmaceuticals Inc (ADMS) , and Ocera Therapeutics Inc (OCRX) among others .
Click here to see the complete history of Rajiv Patni’s form 4 insider trades.
Insider Ownership Summary of Rajiv Patni
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTLA | Portola Pharmaceuticals Inc | 2020-07-02 | EVP & CMO |
| ADMS | Adamas Pharmaceuticals Inc | 2019-04-08 | Chief Medical Officer |
| OCRX | Ocera Therapeutics Inc | 2015-05-07 | Chief Development Officer |
 | | 2023-09-26 | EVP & Chief R&D Officer |
Rajiv Patni Latest Holdings Summary
Rajiv Patni currently owns a total of 2 stocks. Among these stocks, Rajiv Patni owns 19,141 shares of Adamas Pharmaceuticals Inc (ADMS) as of March 20, 2019, with a value of $157,339 and a weighting of 94.57%. Rajiv Patni also owns 5,050 shares of Ocera Therapeutics Inc (OCRX) as of May 7, 2015, with a value of $9,040 and a weighting of 5.43%.
Latest Holdings of Rajiv Patni
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADMS | Adamas Pharmaceuticals Inc | 2019-03-20 | 19,141 | 8.22 | 157,339 |
| OCRX | Ocera Therapeutics Inc | 2015-05-07 | 5,050 | 1.79 | 9,040 |
Holding Weightings of Rajiv Patni
Rajiv Patni Form 4 Trading Tracker
According to the SEC Form 4 filings, Rajiv Patni has made a total of 0 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 2,374 shares on March 20, 2019, which brought Rajiv Patni around $18,992.
According to the SEC Form 4 filings, Rajiv Patni has made a total of 0 transactions in Ocera Therapeutics Inc (OCRX) over the past 5 years. The most-recent trade in Ocera Therapeutics Inc is the acquisition of 5,050 shares on May 7, 2015, which cost Rajiv Patni around $20,049.
Insider Trading History of Rajiv Patni
- 1
Rajiv Patni Trading Performance
GuruFocus tracks the stock performance after each of Rajiv Patni's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rajiv Patni is 2.5%. GuruFocus also compares Rajiv Patni's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rajiv Patni within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rajiv Patni's insider trading performs compared to the benchmark.
Performance of Rajiv Patni
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4 | | | | | |
| Relative Return to S&P 500(%) | -4.23 | | | | | |
Rajiv Patni Ownership Network
Rajiv Patni Owned Company Details
What does Portola Pharmaceuticals Inc do?
Who are the key executives at Portola Pharmaceuticals Inc?
Rajiv Patni is the EVP & CMO of Portola Pharmaceuticals Inc. Other key executives at Portola Pharmaceuticals Inc include EVP & General Counsel John B Moriarty , EVP and CFO Mardi Dier , and director & President and CEO J. Scott Garland .
Portola Pharmaceuticals Inc (PTLA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Portola Pharmaceuticals Inc Insider Transactions
Rajiv Patni Mailing Address
Above is the net worth, insider trading, and ownership report for Rajiv Patni. You might contact Rajiv Patni via mailing address: C/o Ocera Therapeutics, Inc., 525 University Avenue, Suite 610, Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
